Health System Determinants of Hypertension Care and Outcomes in Sub-Saharan Africa: A Systematic Review
=======================================================================================================

* Samuel Byiringiro
* Oluwabunmi Ogungbe
* Yvonne Commodore-Mensah
* Khadijat Adeleye
* Fred Stephen Sarfo
* Cheryl R. Himmelfarb

## Abstract

**Background** Hypertension is a significant global health problem, particularly in Sub-Saharan Africa (SSA). Despite the effectiveness of medications and lifestyle interventions in reducing blood pressure, shortfalls across health systems continue to impede progress in achieving optimal hypertension control rates. The current review explores health system factors contributing to hypertension outcomes in SSA.

**Methods** The World Health Organization health systems framework guided the literature search and discussion of findings. We searched PubMed, CINAHL, and Embase databases for studies published between January 2010 and June 2022 and followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We assessed studies for risk of bias using the tools from Joanna Briggs Institute.

**Results** Thirty-nine studies clustered in 10 SSA countries met inclusion criteria. Health system determinants included human resource factors such as providers’ knowledge and adherence to hypertension treatment guidelines (n=21) and task sharing and shifting strategies (n=10). The second health system factors explored in service delivery were the health facility type and capacity (n=7) and hypertension service accessibility by cost, place, and time of services (n=15). A quarter of the included studies explored supply chain management for access to essential equipment and medicines. An additional set of studies addressed quality improvement strategies involving cross-integration of services (n=7) and various strategies of gauging the systems for better hypertension outcomes (n=8).

**Conclusion** A combination of multiple rather than solo system interventions may yield significant improvements in blood pressure outcomes. Health information management and leadership involvement were less explored. Additional research on health system determinants of hypertension is needed to drive global improvements in hypertension outcomes. Future research would benefit from more rigorous implementation type interventional studies comprehensively assessing health system factors that contribute to better hypertension outcomes.

Keywords
*   hypertension
*   high blood pressure
*   raised blood pressure
*   Sub-Saharan Africa
*   Low- and Middle-Income Countries
*   health system
*   health facilities
*   quality improvement
*   quality of care

## Introduction

Hypertension remains a global health challenge, especially for low- and middle-income countries (LMICs) in Sub-Saharan Africa (SSA) [1]. Hypertension is a significant risk factor for stroke and ischemic heart disease, the world’s deadliest maladies [2]. It is estimated that 30% of the SSA population have hypertension [3–5], 27% are aware of their hypertensive status, and only 7% have their hypertension under control [3]. The prevalence of hypertension in SSA will likely continue to rise due to the rapid shift to sedentary lifestyles, growing urbanization, and a higher number of people living longer [6, 7]. The level of preparedness of health systems for managing hypertension and related sequelae is poor and requires urgent attention [8, 9].

Several strategies have been implemented to manage hypertension in SSA. Population-based interventions such as educational campaigns to improve dietary practices by reducing salt consumption have proven cost-effective in lowering blood pressure among hypertensive patients [10–13]. Alternative interventions implemented to reduce dietary salt include increasing the availability and affordability of healthy foods and reformulation of processed foods with the help of government policies [10]. Other strategies including technology and non-technology based reminders targeted the hypertensive patients to improve their adherence to the prescribed pharmacologic and non-pharmacologic treatments [13, 14]. Despite the numerous, effective interventions targeting the patients with hypertension, the health systems are not equipped to provide the best quality care, yet, the health system is the current epicenter in the population-based hypertension [8, 9].

Multiple guidelines exist for screening, diagnosing, and treating hypertension [2, 15, 16]. The Pan-African Society of Cardiology task force convened in 2014 laid the roadmap to achieving 25% blood pressure control in Africa by 2025[17]. In 2021, the World Heart Federation laid an updated roadmap that identified the major roadblocks in hypertension diagnosis and management and recommended solutions for reducing uncontrolled hypertension by 30% by 2030 [18]. The lack of local hypertension treatment guidelines, protocols, and policies on the procurement and distribution of anti-hypertensives are some of the multiple identified government and health system roadblocks to achieving hypertension control goals [17, 18]. These roadblocks likely result in the lack of community sensitization on hypertension and service inaccessibility through high-cost and centralized hypertension care [19, 20]. According to the Chronic Care Model, the health systems’ role in hypertension management should be to support patients for self-management at home, set up systems to ensure patients follow up after clinical encounters, and decentralize hypertension care closest to patients [20, 21]. Health systems should provide access to specialists if needed, ensure providers are trained and have access to the latest guidelines and decision support, and document care to improve the quality of care [20, 21].

The World Health Organization (WHO) health systems framework highlights six critical elements to target while working to improve the quality of health services. These are the service delivery; health workforce; access to equipment, consumables, and technology; information systems; financing; and leadership and governance. In 2013, the WHO developed the Service Availability and Readiness Assessment (SARA) to map the progress in the six elements of the health systems[22]. The SARA tool has been extensively utilized in maternal and reproductive health and on a minimal basis in cardiovascular health care [23, 24]. The evidence on the health system determinants of hypertension care and outcomes is limited. The current review synthesizes the literature on the health system factors of hypertension care in SSA and identifies the gaps and opportunities for improving the quality of hypertension care.

## Methods

### Search Strategy

Collaborating with a scientific library informationist, we defined the search terms for hypertension service availability and delivery guided by the WHO health systems’ framework [25]. We Identified Medical Subject Headings (MeSH) terms (“Health Facilities,” “Health Services Accessibility,” “Health Care Delivery”); and hypertension (“hypertension” or “elevated blood pressure” or “raised blood pressure” or anti-hypertensive) in SSA. We searched PubMed, Cumulated Index to Nursing and Allied Health Literature (CINAHL), and Embase. The detailed list of search terms is in Supplementary File 1 (S-File 1).

### Study selection and eligibility

The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [26] guided this systematic review (S-File 2). We imported articles from the literature search into Covidence, and three investigators (SB, KA, and OO) conducted the title and abstract screening, full-text review, and final extraction. Two investigators appraised each article independently at each step, and the third investigator resolved any conflicts. Occasionally, the investigators discussed with the supervising faculty (YCM and CRH) to resolve disputes.

In the article search and screening, we included studies (1) published between January 2010 – June 2022; (2) conducted in health facility settings (hospitals, clinics, community health facilities) in SSA; (3) with randomized controlled trials, quasi-experimental, cohort study, case-control study, cross-sectional study designs, and quality improvement projects; (5) which explored the association between healthcare system factors and hypertension awareness, treatment initiation and adherence, and control. The delineation of the search to 2010 was influenced by another systematic review conducted in 2013 exploring the influence of the health system on hypertension awareness, treatment, and control in LMICs [27].

We excluded studies (1) merely describing the prevalence of hypertension and associated patient-level factors, (2) which investigated the health system interventions without exploring association with any of the listed hypertension outcomes, and (3) which explored hypertension care interventions conducted solely in the community setting without describing collaboration with health facilities, or (3) examining patient-level behavioral change interventions for hypertension management. Additionally, we excluded gray literature (books, cases, etc.).

The investigators tracked the rationale for excluding any study during the entire process following the article search as reported in the PRISMA flowchart (Figure 1).

![Fig 1.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2022/10/21/2022.10.19.22280830/F1.medium.gif)

[Fig 1.](http://medrxiv.org/content/early/2022/10/21/2022.10.19.22280830/F1)

Fig 1. PRISMA diagram with flowchart of study screening and inclusion]

### Risk of Bias Assessment

We used the Joanna Briggs Institute (JBI) tools to assess the quality aspects of the methods and conduct of the studies included in the review [28]. We evaluated the quality improvement study using the Standards for Quality Improvement Reporting Excellence 2.0 (SQUIRES) guideline [29]. SQUIRES uses a checklist of standard elements for reports of system-level projects to improve healthcare quality. Two investigators independently assessed the risk of bias for each study and the third resolved conflicts. The JBI tool uses “Yes,” “No,” and “Unclear or Not applicable” to assess the different features of study design and the overall appraisal as include study, exclude study, or seek more information. We replaced “Yes,” “No,” and “Unclear” with “Low risk of bias,” high risk of bias,” and “Some concerns,” respectively. We assigned the overall quality appraisal of each study as “good,” “fair,” and “poor” and studies with poor quality were excluded. We used the robvis [30] online tool to create risk-of-bias plots where the overall appraisal was also converted to “low risk of bias” for the study of good quality, “some concerns” for studies of fair quality and “high risk of bias” for studies of poor quality.

### Analysis and synthesis of findings

After the data extraction, we identified relevant themes of health system factors and interventions for hypertension care. We classified the outcomes of each study in the appropriate group: hypertension awareness, systolic and diastolic blood pressure (BP), treatment initiation and adherence, and BP control. We tracked which factors/interventions are likely to lead to better hypertension outcomes and compared findings across the different countries of SSA. We discussed the results against the other potential areas of health systems crucial to improving the quality of hypertension care as delineated in the WHO health systems framework [25].

## Results

We identified 7,494 studies, yet 3,121 were duplicates (Figure 1). We conducted title and abstract screening for 4,373 studies yielding 205 for full-text review. The latter led to 39 studies for inclusion in this systematic review (Table 1). The quality assessment demonstrated a low risk of bias in 62% (24/39) of the included studies (S-File 3). Given the nature and complexity of health system interventions, the compliance to all requirements of the study design raised some concerns in 38% (15/39) of the included studies. Among randomized controlled trials, the most common issues were the lack of concealed intervention allocation, the similarity of groups at baseline, and blinding participants and those delivering the intervention of the group assignments. The most common concern among cohort studies was the lack of identification and management of confounding factors and strategies to address participants’ loss to follow-up. The identification and management of confounding factors was the most common reason for concern among cross-sectional studies.

View this table:
[Table 1.](http://medrxiv.org/content/early/2022/10/21/2022.10.19.22280830/T1)

Table 1. characteristics of studies examining the association between health system factors or interventions and hypertension outcomes (N=39)

### Country and design of included studies

Of the 39 included studies, six were randomized controlled trials conducted in South Africa (n=2) [31, 32], Cameroon (n=1) [33], Ghana (n=1) [34], Kenya and Uganda (n=1) [35], and Zambia (n=1) [36]. Five quasi-experimental studies were conducted in Nigeria (n=2)[37, 38], Cameroon (n=1) [39], Kenya (n=1) [40], and Sierra Leone (n=1) [41]. Eight cohort studies were conducted in Ethiopia (n=1) [42], Uganda and Tanzania (n=1) [43], Tanzania (n=1) [44], South Africa (n=1) [45], Sierra Leone (n=1) [46], Ghana and Kenya (n=1) [47], Kenya (n=1) [48], The Democratic Republic of the Congo (n=1) [49].

Nineteen cross-sectional studies were conducted in Ethiopia (n=3) [50–52], Nigeria (n=2) [53, 54], Botswana (n=1) [55], Democratic Republic of Congo (n=1) [56], Swaziland now called Eswatini (n=2) [57, 58], Namibia (1) [59], South Africa (n=3) [60–62], Ghana (n=4) [63–66], Kenya (n=2) [67, 68]. We additionally identified one quality improvement report from Botswana [69]. The geographic representation of included studies by country is demonstrated in Figure 2.

![Fig 2.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2022/10/21/2022.10.19.22280830/F2.medium.gif)

[Fig 2.](http://medrxiv.org/content/early/2022/10/21/2022.10.19.22280830/F2)

Fig 2. Distribution of studies on health system factors of hypertension care in Sub-Saharan Africa

### Health system factors and interventions explored

The most studied health system factors were human resource factors – (1) healthcare providers’ knowledge and adherence to hypertension treatment guidelines and decision support systems; and (2) the task-sharing/shifting of hypertension care tasks to unconventional health professionals. Other health system factors related to service delivery included (3) the health facility type and capacity and (4) service accessibility in terms of cost, place, and time of care (Table 2). Additionally, studies explored (5) supply chain management for access to essential equipment and anti-hypertensive medicines. Finally, studies explored the revision of the patient care process at the health facility through (6) the cross-integration of services and (7) the different quality improvement strategies for improving hypertension care.

View this table:
[Table 2.](http://medrxiv.org/content/early/2022/10/21/2022.10.19.22280830/T2)

Table 2. Health system factors and interventions explored and corresponding countries where they were conducted

#### (1) Healthcare providers’ knowledge and adherence to hypertension treatment guidelines and decision support system

Half of the studies (21/39) [32–36, 38–41, 43, 46–49, 53, 55, 57–59, 61] across 13 countries explored the impact of healthcare provider knowledge of or adherence to hypertension treatment guidelines and decision support system on hypertension outcomes (Table 3). Generally, higher provider knowledge of or better adherence to guidelines and availability of decision-making support systems correlated with better hypertension care outcomes. For instance, the lack of physician knowledge in prescribing anti-hypertensives at a University College Hospital in Nigeria demonstrated 76% higher or lower blood level doses (as measured in urine) of anti-hypertensives than recommended and contributed to 35% lower BP control [53]. Adherence to the Eighth Joint National Committee guidelines contributed to 46% of additional patients achieving BP control in Kenya [70]. An approximately similar pattern was observed in a study conducted in Botswana [55].

View this table:
[Table 3.](http://medrxiv.org/content/early/2022/10/21/2022.10.19.22280830/T3)

Table 3. Studies examining the association between health system factors or interventions and hypertension outcomes (N=39)

Improvement in the healthcare providers’ skills and knowledge of the correct blood pressure measurement techniques and hypertension diagnosis, respectively, were effective in managing hypertension in Kenya [40]. In its first year, the program helped screen 532 527 individuals, diagnose almost 10% of them with hypertension, and initiate 72% of those diagnosed on treatment [40]. The provider skills in BP measurement were assessed in Eswatini by comparing the pragmatic measurements with standard sphygmomanometer measurements [57]. The two measurements showed a good agreement of 0.7 Kappa score and an 84% concurrence in hypertension treatment decisions (continuing, changing, adjusting, stopping treatment).

#### (2) Task-sharing/shifting strategy

A quarter of studies (10/39) [32, 34–36, 38, 39, 41, 47, 48, 58] conducted in 9 countries explored the impact of delegating some hypertension care tasks to non-physician providers (task-shifting) or community health workers. The task-shifting consisted of training and giving roles to lay community health workers in South Africa [32] and Zambia [36] to conduct and record the BP measurements, to nurses in Cameroon [39] and Ghana [34] to treat hypertension (including prescribing drugs), and to pharmacists in Nigeria [38] to treat hypertension (prescribe medications) and dispense medications after diagnosis at the health facility.

The impact of task-shifting varied across studies but bent towards positive BP outcomes. In Ghana [34] and Cameroon [39], task-shifting contributed to the significant decline in systolic and diastolic BP but not in the achievement of controlled BP [34, 39]. On the other hand, in the two quasi-experimental studies conducted in Nigeria and Zambia, respectively, the task-shifting contributed to the achievement of controlled BP in Nigeria (AOR 2.27, p: 0.049) from baseline to end line and in Zambia from 13% at baseline to 25% (no p-value reported) among patients who attended at least 2 follow up visits [36, 38]. In a cluster randomized controlled trial conducted in South Africa, the task-shifting to lay community health workers in BP measurement and documentation contributed to higher adherence to appointments (75% vs. 56% patients attending their assigned appointments) but no statistically significant improvements in achieving BP control comparing the intervention to the control group [32].

#### (3) Health facility type and capacity

Eighteen percent (7/39) of the included studies [42, 49, 55, 56, 62, 65, 68] explored the impact of health facility type and capacity on hypertension care and outcomes. The studies highlighted the significant yet inconsistent differences in hypertension outcomes associated with receiving care at either community health post (closer to the community - offering one or very few primary healthcare services), community health center (serving a slightly bigger size of the community - offers the whole package of primary care services), general referral hospital, or specialized clinics. In Botswana, community health posts were three times better than community health clinics in helping patients achieve BP control [55]. In Ethiopia, general referral clinics were almost two times better than specialized clinics [42] in patients’ achievement of BP control. In the Democratic Republic of Congo, there were no significant differences in BP outcomes between general referral hospitals and community health centers [56]. Additionally, the presence of the doctor on a daily basis (OR:1.64; 95% CI:1.17-2.31; *p*=0.004) and a higher mean number of nurses in the clinic (OR: 1.15; 95% CI:1.08-1.23; *p*=0.001) were significantly associated with BP control at the baseline of a randomized controlled trial conducted in South Africa [71].

#### (4) Accessibility of hypertension care (cost, geographic, temporality of service delivery)

The effect of patients’ access to hypertension care on hypertension outcomes was explored in 38% (15/39) of the included studies within seven SSA countries [34, 35, 37, 38, 47, 48, 50–52, 54, 58, 63, 64, 66, 67]. The general trend was that the lower cost of care was significantly associated with better hypertension outcomes. The two quasi-experimental studies conducted in Nigeria and Ghana provided health insurance coverage to the intervention group and to both study arms, respectively [34, 37]. In both studies, the systolic and diastolic BP declined in both study arms with a significant and sharper decline in the intervention arms even though the achievement of BP control was not significantly different in the intervention versus control arms. Two cross-sectional studies in Ethiopia reported that patients’ payment of user fees was associated with 50 times higher odds of uncontrolled BP while paying less than 50 Ethiopian Birr (approximately 1 USD) was associated with two-fold higher odds of achieving BP control [50, 52].

Four studies reported the factors related to the spatial and temporality accessibility of hypertension care services in achieving BP control. The shorter distance to the health facilities [51] and time flexibility at the hypertension care clinics were associated with better hypertension care outcomes [67]. Yet, such patterns were not true in South Africa, where rural dwellers (where people are likely to travel longer to health facilities) were better responders to treatment intensification by achieving BP control compared to urban dwellers (OR: 0.66; 95% CI: 0.45-0.97; p:0.034) [71]. In Ethiopia, traveling less than 30 minutes to the hospital had 2.02 times higher odds of medication adherence compared to traveling 30 minutes or more [51]. Similarly, the flexibility in location (other than at the health facility) and time of day of dispensing medications were associated with better health outcomes, as reported in Kenya [67] and Nigeria. [38] In Kenya, the extension of hypertension service hours to include evening hours led to a two times likelihood of patients’ adherence to anti-hypertensive medications even though patients scheduled to attend weekend clinics had 76% fewer odds of medication adherence [67].

#### (5) Supply chain management for the availability of essential equipment and consumables

A quarter (10/39) of the studies [36, 39–41, 48, 49, 55, 66, 67, 69] across eight countries explored the availability of equipment and consumables involved in hypertension management and impact on BP outcomes. The procurement of drugs and consumables and improvement in the supply chain implemented in the experimental studies and quality improvement project was in combination with other interventions such as providers’ training in Cameroon, Kenya, and Zambia [36, 39, 40], and better data management in Botswana [69]. In these studies, the impact of the equipment and supply chain was not necessarily isolated but undoubtedly contributed to the overall improvements in BP outcomes.

The cross-sectional study conducted in Botswana reported that the medication errors contributed to three times higher odds (Odds Ratio: 3.23; 95% CI 1.75-6.06 p<0.001) of uncontrolled BP. Almost one-third of the errors were dispenser errors caused mainly by the stock out of the medication and reluctance to refer the patients back to the prescriber to provide an alternative medicine [55]. The interventions that showed significant improvement in BP improved not only the availability of the equipment but also the essential anti-hypertensive drugs, as is the case in Kenya [40].

#### (6) Cross-integration of services

The integration of hypertension and other non-communicable diseases services into the well-established health services was explored in 18% (7/39) of the studies in 6 different countries [35, 43, 45, 46, 49, 60, 61]. The most frequent form of cross-integration was the provision of non-communicable diseases services in the Human Immunodeficiency Virus (HIV) and Sexually Transmitted Diseases clinics and the use of existing patient follow-up mechanisms in managing non-communicable diseases.

Predominantly, the cross-integration of services has shown significant improvements in hypertension control. A cohort of patients in South Africa increased in controlled BP from 43% before integration of services to 49% one year after integration [45]. Another cohort of patients in Uganda and Tanzania had a 10% decline in the risk of uncontrolled BP [43]. In Uganda and Kenya, the care for hypertension, diabetes, and HIV were integrated, and additional features of care improved, leading to a 26% higher likelihood of initiating patients on hypertension treatment and a 29% higher likelihood of BP control. In the Democratic Republic of the Congo, hypertension services were integrated into Emergency Primary Clinic. While there was a high rate of new hypertension diagnoses in 97% of the included sample, only 34% remained in care in one year, and other those who remained in care, 71% achieved a systolic BP below 140 mmHg, which is the cut-off used in the country for desired systolic BP [49].

In one instance, the hypertension clinic was built from scratch in Sierra Leone [46]. A cohort of patients followed in that new rural hypertension clinic had BP control go from 6% at baseline to 31% at one year-follow-up [46].

#### (7) Deliberate improvement in the quality of hypertension care

Eight studies [31, 33, 36, 39, 40, 60, 61, 69] conducted in 5 countries explored the additional value of deliberately gauging and improving systems for a better quality of hypertension care. The quality improvement projects included an improved data recording process in Zambia and Botswana [36, 69] and better monitoring through supervision in Cameroon [33] and South Africa [31]. In South Africa, a quality improvement project on improving data recording and adherence to treatment guidelines by providers was implemented through the introduction of a folded guidelines sheet inside the patient file [31]. The project did not contribute to an increase in patients with BP control, and providers reported that the project was overwhelming because of staff shortage [31]. Where quality improvement was implemented jointly with other system components such as improving the supply chain of equipment and consumables in Botswana [69]; providers’ training on hypertension care and task-shifting in Cameroon [33, 39]; supply chain, training, and task-shifting in Zambia [36]; there were better blood pressure outcomes.

## Discussion

This systematic review aimed to assess the health system factors and interventions for hypertension awareness, initiation and adherence to hypertension treatment, and achievement of controlled blood pressure in SSA. A 2013 systematic review in LMICs [27] and a 2015 narrative synthesis in SSA [72] explored the health system determinants of hypertension care and reported consistent findings of factors of hypertension outcomes: cost of care, human resources factors such as adherence to protocols, physical resources factors such as lack of functioning equipment, and lack of treatment guidelines. Our review identified the above and additional health system interventions and factors, including the accessibility factors of care such as place and time of care, the health facility type and capacity, the use of quality improvement strategies, and the cross integration of services.

The healthcare provider’s knowledge and adherence to hypertension treatment guidelines stood out as one of the most studied health system interventions [40, 73, 74]. The capacity building among healthcare providers and the task sharing and shifting of hypertension management roles to vital professionals like nurses, pharmacists, and community health workers align with scientific evidence from developing and developed countries [75, 76]. For instance, the nurses’ role in managing hypertension has evolved from merely measuring and monitoring blood pressure to collaboratively detecting, diagnosing, and referring patients with hypertension and its complications [77, 78]. In many countries and settings, nurses prescribe or dispense anti-hypertensive medications, provide patient education and counseling to ensure medication adherence, and assume leadership roles in spearheading quality improvement projects for better management of hypertension [77]. An estimation of the global gap in clinic visits for hypertension care reported that 50% of LMICs and 86% of lower-income countries have a physician deficit even if patients were to make only three annual visits to the health facilities for their hypertension [79]. Neupane and colleagues recommend shifting some hypertension management tasks to non-physician clinicians to bridge that gap [79]. Interdisciplinary collaboration is the way forward for SSA to provide quality hypertension care to patients; however, regional and national policies must align with and support best practices.

The cross integration of hypertension services is another system-level intervention explored for the management of hypertension. The hypertension services have been frequently integrated with HIV clinics, and this strategy has demonstrated to be effective in helping patients achieve controlled blood pressure in Sierra Leone [46], South Africa [45], and Tanzania and Uganda [43], to name a few examples. There are some reasons why taking lessons from the management of chronic infectious diseases could be effective in hypertension care. The management of chronic infectious diseases, HIV and Tuberculosis, in resource-constrained settings has, despite still-existing challenges, produced strong evidence and effective strategies for managing patients with such complicated chronic health conditions amid, just to name a few; insufficient healthcare professionals [80], inaccessibility of health services [81], and poor information management systems [82]. In addition to demonstrating that task sharing with and task shifting to non-physician healthcare providers is possible and effective [80, 83, 84], the process of managing HIV and Tuberculosis has also demonstrated ways to manage loss to follow up by the use of strong information management systems [82], decentralization of services close to the community [85], and collaboration with community health workers [80, 84]; all the strategies that could be well adapted to hypertension management. One of the information management system strategies that have been effective in HIV and Tuberculosis control and hypertension management in other low-income countries is the patient registries [86–89]. The current review did not find studies exploring patient registries to prevent loss to follow-up in hypertension management.

The hypertension clinics model consists of managing patients with hypertension in their own outpatient unit and was experimented and proved effective in Sierra-Leone [46] and Eswatini [58]. The premise of this strategy is to have well trained healthcare providers and good systems of data management, in some instances to decentralize of hypertension care, and improvement in patient follow-up. The lessons from the management of HIV and Tuberculosis could be applied in those services. It is crucial to ensure that the detachment of hypertension care from the general outpatient department or from the well-equipped hospital does not hamper the patients’ initiation on hypertension treatment through the internal transfer processes and that patients with hypertension continue to receive holistic care for other health problems they might have in addition to hypertension.

While the decentralization of care might address geographic barriers to hypertension care access, other factors of accessibility such as cost of care and time of services require additional and potentially different interventions. Extensively, the current and previous literature have shown that the high direct and indirect costs of care hamper patients’ use of health services and lead to poor health outcomes and among patients with hypertension, poor blood pressure control [54, 66, 90]. The time of operation of clinics, though limited evidence exists, has an impact on the staffing hence the long queues of patients at the in- and outpatient departments which discourages patients’ attendance to their appointments and encourages loss to follow-up [67, 91, 92]. Universal health coverage through government-subsidized insurance premiums has been advocated as a solution to prevent catastrophic spending on healthcare services and associated poor health outcomes [93–95], and the 24/7 hypertension clinic operation could be explored as a potential intervention to the long waiting queues at the clinics. The financing of universal health coverage and the 24/7 open clinics, however, require political buy-in and collaboration across sectors, local and international [94].

While leadership and governance are central to the success of any endeavor to improve the quality of care, their role and impact in advancing hypertension care in SSA are not widely researched, and the few existing studies are predominantly of poor quality [96]. Thornton highlighted the critical values of leadership commitment, willingness to fund care, strategic and creative local and foreign partnerships, and evidence-based guidelines as the key reasons why Botswana surpassed the United Nations’ HIV management goals of 95% awareness, 95% on treatment, and 95% [81]. A 3-year campaign mobilization on the role of clinical leaders in hypertension management at various health systems in the United States achieved the goal of 80% blood pressure control within seven months [97]. A scoping review of interventions to strengthen the health professionals’ leadership in SSA found that the opportunities for leadership development in SSA are scarce and those available are of poor quality and lacking a consistent evaluation framework [98]. There is a need for more studies on strengthening leadership in healthcare and exploring its impact on health outcomes, including hypertension in SSA.

As the burden of hypertension increases globally, the investment required of health systems to manage hypertension is rising. Hypertension is significantly associated with adverse outcomes of Coronavirus Disease 2019 (COVID-19), the ongoing pandemic ravaging the entire world’s health systems [99, 100]. Studies reported that hypertensive patients had almost three times the odds of mortality compared to people without hypertension [99]. The long-term post-COVID symptoms haunt the patients with hypertension who survive COVID-19 more than the general population [101]. For instance, patients with hypertension are twice as likely to have migraine-like headaches and 68% higher odds of poor sleep than people without hypertension [101]. Apart from the COVID-19 rationale, under the Sustainable Development Goal (SDG) 3 (Ensure healthy lives and promote well-being for all at all ages), target 3.4 aims to reduce by one-third the premature mortality from non-communicable diseases [102]. The management of hypertension, a significant risk factor for cardiovascular diseases, is a step closer to achieving target 3.4 of SDG 3.

Standard tools for exploring the health system determinants for specific diseases are scarce in the realm of hypertension care in Africa. There is a dire need for psychometric tools to explore health system readiness to provide quality hypertension care. The availability of those tools would open doors to researchers interested in hypertension care to gather quality data on health system determinants and render the evidence to policymakers to develop policies directed at shortfalls in care delivery to improve the health outcomes of patients with hypertension.

Future studies are recommended to explore the roles of leadership and governance and information systems at the health facilities levels as well as multi-level approaches (ie, individual, community, provider, health system) in the improvement of hypertension care [27, 72]. Additionally, while the current review explored studies conducted in SSA, most of the studies were conducted in three countries (Ethiopia, South Africa, and Ghana). Future studies should explore hypertension service readiness in other countries of SSA. The expansion of studies exploring health system factors of hypertension care could be a way to highlight the areas of need to advocate for support from local and international health agencies.

### Strengths and Limitations

The strengths of the current review are the holistic view of health system factors and interventions that affect the quality of hypertension service delivery, stringent critique of the quality of the studies, and the overall derivation conclusion against the WHO framework [25]. Nevertheless, the current review included only studies published in English and did not include the gray literature, which could consist of unpublished reports, and quality improvement projects on the health system interventions to improve hypertension service delivery. While the review attempted to isolate the effect of the individual health system factors, many system interventions were delivered in a bundled approach which rendered the isolation impossible.

## Conclusion

The literature exploring health system factors of hypertension outcomes in SSA is limited in volume and quality. The combination of multiple health system interventions was likely to result in better hypertension outcomes. More rigorously designed studies about the different aspects of the health systems and their impact on hypertension outcomes, especially the health information management and leadership and management are needed in SSA to inform effective hypertension control efforts.

## Supporting information

S-File 1. Search Terms [[supplements/280830_file05.docx]](pending:yes)

S-File 2. PRISMA 2009 Checklist [[supplements/280830_file06.doc]](pending:yes)

S-File 3. JBI Quality Assessment Results [[supplements/280830_file07.docx]](pending:yes)

S-File 4. SQUIRES [[supplements/280830_file08.docx]](pending:yes)

## Data Availability

The search terms used in the literature search have been provided in Supplementary File 1 and tables with the extracted data have been provided in the manuscript.

## Declarations

### Ethics approval and consent to participate

The current study did not involve human subject research, and the ethical approval or consent to participate is not applicable

### Consent for publication

All authors reviewed and approved the final manuscript for publication

### Competing interest

We have no conflict of interest to declare

### Funding

Not applicable

### Authors’ contributions

SB: Idea conception, literature search, title, and abstract review, full-text review, quality assessment, data extraction, analysis, and drafting of the manuscript

OO: Full-text review, quality assessment, manuscript drafting

FSS: Critical manuscript review, field expertise incorporation in the discussion of findings YCM: Critical manuscript review, language editing, supervision

KA: Full-text review, quality assessment, data extraction, analysis, and revision of the manuscript

CRH: Idea conception, design of literature search and inclusion and exclusion criteria, critical manuscript review, language editing, supervision

## Authors’ information

**Samuel Byiringiro**

Ph.D. Candidate at Johns Hopkins University School of Nursing

525 N Wolfe St, Baltimore, Maryland, 21205

United States

**Oluwabunmi Ogungbe**

Post-doctoral fellow at Johns Hopkins University School of Nursing

N Wolfe St, Baltimore, Maryland, 21205

United States

**Yvonne Commodore-Mensah**

Associate Professor at Johns Hopkins University School of Nursing

525 N Wolfe St, Baltimore, Maryland, 21205

United States

**Khadijat Adeleye**

Ph.D. Student at the University of Massachusetts

Elaine Marieb College of Nursing

Amherst, Massachusetts, 01002

United States of America

**Fred Stephen Sarfo**

Professor of Medicine at Kwame Nkrumah University of Science & Technology, Department of

Medicine

Accra Rd, Kumasi, Ghana

Clinician at Komfo Anokye Teaching Hospital

Okomfo Anokye Road, Kumasi, Ghana

**Cheryl R. Himmelfarb**

Sarah E. Allison Endowed Professor and Vice Dean for Research, Johns Hopkins University

School of Nursing, Joint Appointments in Schools of Medicine and Public Health

N Wolfe St, Baltimore, Maryland, 21205

United States

## Supporting information

S-File 1. Search terms

S-File 3. PRISMA 2009 checklist

S-File 3. JBI Quality Assessment Results

S-File 4. Standards for Quality Improvement Reporting Excellence

## Acknowledgments

We acknowledge the support of Stella Seal, the Library Informationist who helped in searching the databases, Dr. Sarah Szanton and Dr. William E. Rosa for the contribution of ideas in project ideation and discussion of findings, and Dr. Emmanuel Uwiringiyimana for the assistance in the full-text screening.

## List of abbreviations

CINAHL
:   Cumulated Index to Nursing and Allied Health Literature
JBI
:   Joanna Briggs Institute
HIV
:   Human Immunodeficiency Virus
LMIC
:   Low- and Middle-Income Countries
PRISMA
:   Preferred Reporting Items for Systematic Reviews and Meta-Analyses
SARA
:   Service Availability and Readiness Assessment
SDG
:   Sustainable Development Goals
COVID-19
:   Coronavirus Disease 2019
SQUIRES
:   Standards for Quality Improvement Reporting Excellence
SSA
:   Sub-Saharan Africa
WHO
:   World Health Organization

*   Received October 19, 2022.
*   Revision received October 19, 2022.
*   Accepted October 21, 2022.


*   © 2022, Posted by Cold Spring Harbor Laboratory

This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/)

## References

1.  [1].World Health Organization (WHO). Hypertension Facts Sheet, [https://www.who.int/news-room/fact-sheets/detail/hypertension](https://www.who.int/news-room/fact-sheets/detail/hypertension) (accessed 7 October 2020).
    
    

2.  [2].Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol 2018; 71: e127 LP–e248.
    
    

3.  [3].Ataklte F, Erqou S, Kaptoge S, et al. Burden of undiagnosed hypertension in sub-saharan Africa: a systematic review and meta-analysis. Hypertension 2015; 65: 291–298.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

4.  [4].Guwatudde D, Nankya-Mutyoba J, Kalyesubula R, et al. The burden of hypertension in sub-Saharan Africa: A four-country cross sectional study. BMC Public Health 2015; 15: 1211.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/s12889-015-2546-z&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

5.  [5].Desormais I, Amidou SA, Houehanou YC, et al. The prevalence, awareness, management and control of hypertension in men and women in Benin, West Africa: The TAHES study. BMC Cardiovasc Disord 2019; 19: 303.
    
    

6.  [6].van de Vijver S, Akinyi H, Oti S, et al. Status report on hypertension in Africa - Consultative review for the 6th Session of the African Union Conference of Ministers of Health on NCD’s. Pan African Medical Journal 2013; 16: 1937–8688.
    
    

7.  [7].Twagirumukiza M, De Bacquer D, Kips JG, et al. Current and projected prevalence of arterial hypertension in sub-Saharan Africa by sex, age and habitat: An estimate from population studies. Journal of Hypertension 2011; 29: 1243–1252.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1097/HJH.0b013e328346995d&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=21540748&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000291480800001&link_type=ISI) 

8.  [8].Adinan J, Manongi R, Temu GA, et al. Preparedness of health facilities in managing hypertension & diabetes mellitus in Kilimanjaro, Tanzania: a cross sectional study. BMC Health Serv Res 2019; 19: 537.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

9.  [9].Deuboué Tchialeu RI, Yaya S, Labonté R. Health Systems Readiness to Manage the Hypertension Epidemic in Primary Health Care Facilities in the Western Cape, South Africa: A Study Protocol. JMIR Res Protoc 2016; 5: e35.
    
    

10. [10].Muthuri SK, Oti SO, Lilford RJ, et al. Salt reduction interventions in sub-Saharan Africa: A systematic review. PLoS ONE 2016; 11: e0149680.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1371/journal.pone.0149680&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=26963805&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

11. [11].Ireland DM, Clifton PM, Keogh JB. Achieving the Salt Intake Target of 6 g/Day in the Current Food Supply in Free-Living Adults Using Two Dietary Education Strategies. J Am Diet Assoc 2010; 110: 763–767.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.jada.2010.02.006&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=20430138&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

12. [12].Adeyemo AA, Prewitt TE, Luke A, et al. The feasibility of implementing a dietary sodium reduction intervention among free-living normotensive individuals in south west Nigeria. Ethn Dis 2002; 12: 207–212.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=12019929&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

13. [13].Cappuccio FP, Miller MA. Cardiovascular disease and hypertension in sub-Saharan Africa: burden, risk and interventions. Intern Emerg Med 2016; 11: 299–305.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s11739-016-1423-9&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

14. [14].Ogungbe O, Byiringiro S, Adedokun-Afolayan A, et al. Medication Adherence Interventions for Cardiovascular Disease in Low-and Middle-Income Countries: A Systematic Review. Patient Prefer Adherence 2021; 15: 885.
    
    

15. [15].Whelton PK, Williams B. The 2018 European Society of Cardiology/European Society of Hypertension and 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines: More Similar Than Different. JAMA - Journal of the American Medical Association 2018; 320: 1749–1750.
    
    

16. [16].Armstrong C. JNC 8 guidelines for the management of hypertension in adults. American Family Physician 2014; 90: 503–504.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=25369633&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

17. [17].Dzudie A, Rayner B, Ojji D, et al. Roadmap to achieve 25% hypertension control in Africa by 2025. Cardiovasc J Afr 2017; 28: 262–273.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

18. [18].Jeemon P, Séverin T, Amodeo C, et al. World heart federation roadmap for hypertension – A 2021 update. Glob Heart 2021; 16: 63.
    
    

19. [19].Nulu S, Aronow WS, Frishman WH. Hypertension in Sub-Saharan Africa: A Contextual View of Patterns of Disease, Best Management, and Systems Issues. Cardiol Rev 2016; 24: 30–40.
    
    

20. [20].Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Effective clinical practice_J: ECP 1998; 1: 2–4.
    
    

21. [21].Crisp N. Health is made at home, hospitals are for repairs: Building a healthy and healthcreating society.
    
    

22. [22].World Health Organization (WHO). Service Availability and Readiness Assessment (SARA): An annual monitoring system for service delivery - Reference Manual, Version 2.2. Health Statistics and Information Systems 2015; 175.
    
    

23. [23].Kozuki N, Oseni L, Mtimuni A, et al. Health facility service availability and readiness for intrapartum and immediate postpartum care in Malawi: A cross-sectional survey. PLoS One; 12. Epub ahead of print 1 March 2017. DOI: 10.1371/journal.pone.0172492.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1371/journal.pone.0172492&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=28301484&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

24. [24].Kanyangarara M, Chou VB, Creanga AA, et al. Linking household and health facility surveys to assess obstetric service availability, readiness and coverage: Evidence from 17 low- and middle-income countries. J Glob Health; 8. Epub ahead of print 2018. DOI: 10.7189/jogh.08.010603.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.7189/jogh.08.010603&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=29862026&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

25. [25].WHO. Monitoring the Building Blocks of Health SystemsLJ: a Handbook of Indicators and. 2010; 110.
    
    

26. [26].Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ (Online) 2009; 339: 332–336.
    
    

27. [27].Maimaris W, Paty J, Perel P, et al. The Influence of Health Systems on Hypertension Awareness, Treatment, and Control: A Systematic Literature Review. PLoS Med; 10. Epub ahead of print 2013. DOI: 10.1371/journal.pmed.1001490.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1371/journal.pmed.1001490&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=23935461&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

28. [28].Aromataris E and Munn Z. JBI Reviewer‘s Manual. The Joanna Briggs Institute 2017; 32.
    
    

29. [29].Ogrinc G, Davies L, Goodman D, et al. SQUIRE 2.0 (*Standards for QUality Improvement Reporting Excellence)*: revised publication guidelines from a detailed consensus process. BMJ Quality &amp; Safety 2016; 25: 986 LP – 992.
    
    

30. [30].McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods; n/a. Epub ahead of print 26 April 2020. DOI: 10.1002/jrsm.1411.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/jrsm.1411&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=32336025&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

31. [31].Steyn K, Lombard C, Gwebushe N, et al. Implementation of national guidelines, incorporated within structured diabetes and hypertension records at primary level care in Cape Town, South Africa: a randomised controlled trial. Glob Health Action 2013; 6: 20796.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

32. [32].Goudge J, Chirwa T, Eldridge S, et al. Can lay health workers support the management of hypertension? Findings of a cluster randomised trial in South Africa. BMJ Glob Health 2018; 3: e000577–e000577.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NToiYm1qZ2giO3M6NToicmVzaWQiO3M6MTE6IjMvMS9lMDAwNTc3IjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjIvMTAvMjEvMjAyMi4xMC4xOS4yMjI4MDgzMC5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 

33. [33].Kingue S, Angandji P, Menanga AP, et al. Efficiency of an intervention package for arterial hypertension comprising telemanagement in a Cameroonian rural setting: The TELEMED-CAM study. Pan Afr Med J 2013; 15: 153.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

34. [34].Ogedegbe G, Plange-Rhule J, Gyamfi J, et al. Health insurance coverage with or without a nurse-led task shifting strategy for hypertension control: A pragmatic cluster randomized trial in Ghana. PLoS Med 2018; 15: 1–17.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1371/journal.pmed.1002508&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

35. [35].Hickey MD, Ayieko J, Owaraganise A, et al. Effect of a patient-centered hypertension delivery strategy on all-cause mortality: Secondary analysis of SEARCH, a community-randomized trial in rural Kenya and Uganda. PLoS Med 2021; 18.
    
    

36. [36].Yan LD, Chirwa C, Chi BH, et al. Hypertension management in rural primary care facilities in Zambia: a mixed methods study. BMC Health Serv Res 2017; 17: 111.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

37. [37].Hendriks ME,  Wit Fwnmnm, Akande TM, et al. Effect of health insurance and facility quality improvement on blood pressure in adults with hypertension in Nigeria: a population-based study. JAMA Intern Med 2014; 174: 555–563.
    
    

38. [38].Nelissen HE, Cremers AL, Okwor TJ, et al. Pharmacy-based hypertension care employing mHealth in Lagos, Nigeria - a mixed methods feasibility study. BMC Health Serv Res 2018; 18: 934.
    
    

39. [39].Labhardt ND, Balo J-R, Ndam M, et al. Task shifting to non-physician clinicians for integrated management of hypertension and diabetes in rural Cameroon: a programme assessment at two years. BMC Health Serv Res 2010; 10: 339.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/1472-6963-10-339&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=21144064&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

40. [40].Ogola EN, Okello FO, Herr JL, et al. Healthy Heart Africa-Kenya: A 12-Month Prospective Evaluation of Program Impact on Health Care Providers’ Knowledge and Treatment of Hypertension. Glob Heart 2019; 14: 61–70.
    
    

41. [41].Zou G, Witter S, Caperon L, et al. Adapting and implementing training, guidelines and treatment cards to improve primary care-based hypertension and diabetes management in a fragile context: results of a feasibility study in Sierra Leone. BMC Public Health 2020; 20: 1185.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

42. [42].Berhe DF, Taxis K, Haaijer-Ruskamp FM, et al. Hypertension treatment practices and its determinants among ambulatory patients: retrospective cohort study in Ethiopia. BMJ Open 2017; 7: e015743–e015743.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoiYm1qb3BlbiI7czo1OiJyZXNpZCI7czoxMToiNy84L2UwMTU3NDMiO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyMi8xMC8yMS8yMDIyLjEwLjE5LjIyMjgwODMwLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 

43. [43].Birungi J, Kivuyo S, Garrib A, et al. Integrating health services for HIV infection, diabetes and hypertension in sub-Saharan Africa: a cohort study. BMJ Open 2021; 11: e053412..
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoiYm1qb3BlbiI7czo1OiJyZXNpZCI7czoxMzoiMTEvMTEvZTA1MzQxMiI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDIyLzEwLzIxLzIwMjIuMTAuMTkuMjIyODA4MzAuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 

44. [44].Miselli MA, Cavallin F, Marwa S, et al. An integrated management system for noncommunicable diseases program implementation in a sub-saharan setting. Int J Environ Res Public Health 2021; 18.
    
    

45. [45].Gausi B, Berkowitz N, Jacob N, et al. Treatment outcomes among adults with HIV/non-communicable disease multimorbidity attending integrated care clubs in Cape Town, South Africa. AIDS Res Ther 2021; 18: 72.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

46. [46].Kachimanga C, Dibba Y, Patiño M, et al. Implementation of a non-communicable disease clinic in rural Sierra Leone: early experiences and lessons learned. J Public Health Policy 2021; 42: 422–438.
    
    

47. [47].Otieno HA, Miezah C, Yonga G, et al. Improved blood pressure control via a novel chronic disease management model of care in sub-Saharan Africa: Real-world program implementation results. J Clin Hypertens 2021; 23: 785–792.
    
    

48. [48].Vedanthan R, Kumar A, Kamano JH, et al. Effect of nurse-based management of hypertension in Rural Western Kenya. Glob Heart 2020; 15.
    
    

49. [49].Ratnayake R, Wittcoff A, Majaribu J, et al. Early experiences in the integration of non-communicable diseases into emergency primary health care, beni region, democratic republic of the Congo. Ann Glob Health 2021; 87.
    
    

50. [50].Asgedom SW, Atey TM, Desse TA. Antihypertensive medication adherence and associated factors among adult hypertensive patients at Jimma University Specialized Hospital, southwest Ethiopia. BMC Res Notes 2018; 11: 27.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

51. [51].Ambaw AD, Alemie GA, W/Yohannes SM, et al. Adherence to antihypertensive treatment and associated factors among patients on follow up at University of Gondar Hospital, Northwest Ethiopia. BMC Public Health 2012; 12: 282.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/1471-2458-12-282&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=22490130&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

52. [52].Mekonnen HS, Gebrie MH, Eyasu KH, et al. Drug adherence for antihypertensive medications and its determinants among adult hypertensive patients attending in chronic clinics of referral hospitals in Northwest Ethiopia. BMC Pharmacol Toxicol 2017; 18: 27.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

53. [53].Akunne OO, Adedapo ADA. Antihypertensive prescription among black patients without compelling indications: prescription, effectiveness, quality and cost of medication. BMC Health Serv Res 2019; 19: 373.
    
    

54. [54].Adedapo ADA, Sikuade O, Adeleke S, et al. Drug utilization and blood pressure control in a population where antihypertensives are given free: effect of policy change. Afr J Med Med Sci 2012; 41: 349–356.
    
    

55. [55].Gala P, Moshokgo V, Seth B, et al. Medication Errors and Blood Pressure Control Among Patients Managed for Hypertension in Public Ambulatory Care Clinics in Botswana. J Am Heart Assoc 2020; 9: 1–10.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

56. [56].Lulebo AM, Kaba DK, Atake SE-H, et al. Task shifting in the management of hypertension in Kinshasa, Democratic Republic of Congo: a cross-sectional study. BMC Health Serv Res 2017; 17: 698.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

57. [57].Mlawanda G, Pather M, Govender S. An analysis of blood pressure measurement in a primary care hospital in Swaziland. Afr J Prim Health Care Fam Med 2014; 6: E1–E9.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.4102/phcfm.v6i1.726&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=26245386&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

58. [58].Sharp A, Riches N, Mims A, et al. Decentralising NCD management in rural southern Africa: evaluation of a pilot implementation study. BMC Public Health 2020; 20: 44.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

59. [59].Mashozhera S, Bamitale SK, Godman B, et al. Compliance to hypertensive prescribing guidelines and blood pressure control in elderly patients in Namibia: Findings and implications. Journal of Pharmaceutical Health Services Research 2021; 12: 53–60.
    
    

60. [60].Ameh S. Evaluation of an integrated HIV and hypertension management model in rural south africa: a mixed methods approach. Glob Health Action 2020; 13: 1750216.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

61. [61].Pfister C-L, Govender S, Dyer RA, et al. A multicenter, cross-sectional quality improvement project: The perioperative implementation of a hypertension protocol by anesthesiologists. Anesth Analg 2020; 1401–1408.
    
    

62. [62].Pillay S, Pillay D, Pillay RS. The burden of hypertension in KwaZulu-Natal Province, South Africa: A 6-year perspective. South African Medical Journal 2021; 111: 159–165.
    
    

63. [63].Harrison MA, Marfo AFA, Opare-Addo MNA, et al. Anti-hypertensive medication access and affordability and their association with blood pressure control at a teaching hospital in ghana. Pan African Medical Journal 2021; 39.
    
    

64. [64].Menyanu EK, Corso B, Minicuci N, et al. Determinants of change in blood pressure in Ghana: Longitudinal data from WHO-SAGE Waves 1-3. PLoS One 2021; 16.
    
    

65. [65].Sarfo FS, Ovbiagele B. Apparent Treatment Resistant Hypertension Among Stroke Survivors in Ghana. Journal of Stroke and Cerebrovascular Diseases 2020; 29.
    
    

66. [66].Adomako NO, Marfo AFA, Opare-Addo MNA, et al. Blood Pressure Control, Accessibility, and Adherence to Antihypertensive Medications: Patients Seeking Care in Two Hospitals in the Ashanti Region of Ghana. Int J Hypertens 2021; 2021.
    
    

67. [67].Kuria N, Reid A, Owiti P, et al. Compliance with follow-up and adherence to medication in hypertensive patients in an urban informal settlement in Kenya: comparison of three models of care. Trop Med Int Health 2018; 23: 785–794.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

68. [68].Mbau L, Harrison R, Kizito W, et al. Case identification, retention and blood pressure control in Kenya. Public Health Action 2022; 12: 58–63.
    
    

69. [69].Kande C, Mash R. Improving the quality of care for patients with hypertension in Moshupa District, Botswana: quality improvement cycle. Afr J Prim Health Care Fam Med 2014; 6: E1–E4.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.4102/phcfm.v6i1.726&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=26245386&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

70. [70].Mbui JM, Oluka MN, Guantai EM, et al. Prescription patterns and adequacy of blood pressure control among adult hypertensive patients in Kenya; findings and implications. Expert Rev Clin Pharmacol 2017; 10: 1263–1271.
    
    

71. [71].Folb N, Bachmann MO, Bateman ED, et al. Socioeconomic and modifiable predictors of blood pressure control for hypertension in primary care attenders in the Western Cape, South Africa. S Afr Med J 2016; 106: 1241–1246.
    
    

72. [72].Iwelunmor J, Plange-Rhule J, Airhihenbuwa CO, et al. A Narrative Synthesis of the Health Systems Factors Influencing Optimal Hypertension Control in Sub-Saharan Africa. PLoS One 2015; 10: e0130193–e0130193.
    
    

73. [73].Brunström M, Ng N, Dahlström J, et al. Association of Physician Education and Feedback on Hypertension Management With Patient Blood Pressure and Hypertension Control. JAMA Netw Open 2020; 3: e1918625–e1918625.
    
    

74. [74].Abegaz TM, Tefera YG,  Befekadu Abebe T. Target Organ Damage and the Long Term Effect of Nonadherence to Clinical Practice Guidelines in Patients with Hypertension: A Retrospective Cohort Study. Int J Hypertens 2017; 1–8.
    
    

75. [75].Di Palo KE, Kish T. The role of the pharmacist in hypertension management. Curr Opin Cardiol 2018; 33: 382–387.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1097/HCO.0000000000000527&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=29697544&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

76. [76].Gyamfi J, Plange-Rhule J, Iwelunmor J, et al. Training nurses in task-shifting strategies for the management and control of hypertension in Ghana: a mixed-methods study. BMC Health Serv Res 2017; 17: 1–9.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/s12913-017-2552-1&link_type=DOI) 

77. [77].Himmelfarb CRD, Commodore-Mensah Y, Hill MN. Expanding the Role of Nurses to Improve Hypertension Care and Control Globally. Ann Glob Health 2016; 82: 243–253.
    
    

78. [78].Odonkor ST, Frimpong K. Burnout among Healthcare Professionals in Ghana: A Critical Assessment. Biomed Res Int 2020; 2020: 1614968.
    
    

79. [79].Neupane D, Gao Y, Feng Y, et al. Estimation of the Global Gap in Clinic Visits for Hypertension Care between Patient Need and Physician Capacity. Hypertension 2021; 779–786.
    
    

80. [80].Peresu E, Heunis JC, Kigozi NG, et al. Task-shifting directly observed treatment and multidrug-resistant tuberculosis injection administration to lay health workers: stakeholder perceptions in rural Eswatini. Hum Resour Health; 18. Epub ahead of print 1 December 2020. DOI: 10.1186/S12960-020-00541-4.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/S12960-020-00541-4&link_type=DOI) 

81. [81].Thornton J. Botswana’s HIV/AIDS success. The Lancet 2022; 400: 480–481.
    
    

82. [82].Fraser HSFF, Allen C, Bailey C, et al. Information systems for patient follow-up and chronic management of HIV and tuberculosis: a life-saving technology in resource-poor areas. J Med Internet Res 2007; 9: e29–e29.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.2196/jmir.9.4.e29&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=17951213&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

83. [83].Suzan-Monti M, Blanche J, Boyer S, et al. Benefits of task-shifting HIV care to nurses in terms of health-related quality of life in patients initiating antiretroviral therapy in rural district hospitals in Cameroon [Stratall Agence Nationale de Recherche sur le SIDA (ANRS) 12110/Ensemble pour une Solidarité Thérapeutique Hospitalière en Réseau (ESTHER) substudy]. HIV Med 2015; 16: 307–318.
    
    

84. [84].Busza J, Dauya E, Bandason T, et al. The role of community health workers in improving HIV treatment outcomes in children: lessons learned from the ZENITH trial in Zimbabwe. Health Policy Plan 2018; 33: 328–334.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

85. [85].Loubiere S, Boyer S, Protopopescu C, et al. Decentralization of HIV care in Cameroon: Increased access to antiretroviral treatment and associated persistent barriers. Health Policy (New York) 2009; 92: 165–173.
    
    

86. [86].Lancet T. National disease registries for advancing health care. The Lancet 2011; 378: 2050.
    
    

87. [87].O’Brien E. How Registries Can Guide Our Future? Hypertension 2017; 69: 198–199.
    
    

88. [88].Myanganbayar M, Baatarsuren U, Chen G, et al. Hypertension knowledge, attitudes, and practices of nurses and physicians in primary care in Ulaanbaatar Mongolia. J Clin Hypertens 2019; 21: 1202–1209.
    
    

89. [89].Chan BTB, Rauscher C, Issina AM, et al. A programme to improve quality of care for patients with chronic diseases, Kazakhstan. Bull World Health Organ 2020; 98: 161–169.
    
    

90. [90].Gnugesser E, Chwila C, Brenner S, et al. The economic burden of treating uncomplicated hypertension in Sub-Saharan Africa: a systematic literature review. BMC Public Health 2022; 22: 1507.
    
    

91. [91].Wagenaar BH, Gimbel S, Hoek R, et al. Wait and consult times for primary healthcare services in central Mozambique: a time-motion study. Glob Health Action; 9. Epub ahead of print 1 December 2016. DOI: 10.3402/GHA.V9.31980.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3402/GHA.V9.31980&link_type=DOI) 

92. [92].Son YJ, Lee EK, Ko Y. Association of Working Hours and Patient Safety Competencies with Adverse Nurse Outcomes: A Cross-Sectional Study. Int J Environ Res Public Health; 16. Epub ahead of print 1 November 2019. DOI: 10.3390/IJERPH16214083.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3390/IJERPH16214083&link_type=DOI) 

93. [93].de Maeseneer J, Li D, Palsdottir B, et al. Universal health coverage and primary health care: the 30 by 2030 campaign. Bull World Health Organ 2020; 98: 812.
    
    

94. [94].Greer SL, Méndez CA. Universal Health Coverage: A Political Struggle and Governance Challenge. Am J Public Health 2015; 105: S637.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.2105/AJPH.2015.302733&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=26180991&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

95. [95].American Public Health Association. The Importance of Universal Health Care in Improving Our Nation’s Response to Pandemics and Health Disparities, [https://www.apha.org/Policies-and-Advocacy/Public-Health-Policy-Statements/Policy-Database/2021/01/14/The-Importance-of-Universal-Health-Care-in-Improving-Response-to-Pandemics-and-Health-Disparities](https://www.apha.org/Policies-and-Advocacy/Public-Health-Policy-Statements/Policy-Database/2021/01/14/The-Importance-of-Universal-Health-Care-in-Improving-Response-to-Pandemics-and-Health-Disparities) (accessed 18 August 2022).
    
    

96. [96].Johnson O, Begg K, Kelly AH, et al. Interventions to strengthen the leadership capabilities of health professionals in Sub-Saharan Africa: a scoping review. Health Policy Plan 2021; 36: 117–133.
    
    

97. [97].Lustig A, Ogden M, Brenner RW, et al. The Central Role of Physician Leadership for Driving Change in Value-Based Care Environments. J Manag Care Spec Pharm 2016; 22: 1116–1122.
    
    

98. [98].Johnson O, Begg K, Kelly AH, et al. Interventions to strengthen the leadership capabilities of health professionals in Sub-Saharan Africa: a scoping review. Health Policy Plan 2021; 36: 117–133.
    
    

99. [99].Liang X, Shi L, Wang Y, et al. The association of hypertension with the severity and mortality of COVID-19 patients: Evidence based on adjusted effect estimates. J Infect 2020; 81: e44–e47.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.jinf.2020.06.060&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

100.[100].de Almeida-Pititto B, Dualib PM, Zajdenverg L, et al. Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis. Diabetol Metab Syndr 2020; 12: 75.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/s13098-020-00586-4&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F10%2F21%2F2022.10.19.22280830.atom) 

101.[101].Fernández-de-las-Peñas C, Torres-Macho J, Velasco-Arribas M, et al. Preexisting hypertension is associated with a greater number of long-term post-COVID symptoms and poor sleep quality: a case–control study. Journal of Human Hypertension 2022 36:6 2022; 36: 582–584.
    
    

102.[102].United Nations. Department of Economic and Social Affairs | Sustainable Development Goals, [https://sdgs.un.org/goals/goal3](https://sdgs.un.org/goals/goal3) (2020, accessed 4 November 2020).